NutriBand (NTRB) Free Cash Flow (2016 - 2026)
NutriBand's (NTRB) quarterly Free Cash Flow came in at -$731830.0 in Q1 2026, up 40.95% year-on-year from -$519229.3 in Q1 2025, and up 58.24% quarter-over-quarter from -$1.8 million in Q4 2025.
NutriBand (NTRB) Free Cash Flow (2016 - 2026) Analysis & Trends
NutriBand has disclosed Free Cash Flow across 11 years of filings, most recently posting -$731830.0 for Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$731830.0, up 40.95% year-over-year; the trailing twelve-month figure through Jan 2026 was -$5.1 million (down 8.93% YoY), and the FY2026 annual result was -$5.1 million, down 8.93% from the prior year.
- Free Cash Flow came in at -$731830.0 for Q1 2026 at NutriBand, up from -$1.8 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$521715.0 in Q4 2022 to a low of -$1.8 million in Q4 2025.
- The 5-year median for Free Cash Flow is -$995135.0 (2023), against an average of -$1.0 million.
- Peak annual rise in Free Cash Flow reached 56.91% in 2022, while the deepest fall reached 1418.58% in 2022.
- NutriBand's Free Cash Flow stood at -$521715.0 in 2022, then sank by 103.99% to -$1.1 million in 2023, then grew by 0.72% to -$1.1 million in 2024, then slumped by 65.86% to -$1.8 million in 2025, then soared by 58.24% to -$731830.0 in 2026.
- The last three Free Cash Flow figures came in at -$731830.0 (Q1 2026), -$1.8 million (Q4 2025), and -$1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 63,220.27 |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 | -731,830.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -731,830.00 |
| Jan 31, 2026 | -731,830.00 |
| Oct 31, 2025 | -1.75 Mn |
| Oct 31, 2025 | -1.75 Mn |
| Jul 31, 2025 | -1.31 Mn |
| Jul 31, 2025 | -1.31 Mn |
| Apr 30, 2025 | -1.34 Mn |
| Apr 30, 2025 | -1.34 Mn |
| Jan 31, 2025 | -1.24 Mn |
| Jan 31, 2025 | -1.24 Mn |
| Oct 31, 2024 | -1.06 Mn |
| Oct 31, 2024 | -1.06 Mn |
| Jul 31, 2024 | -1.58 Mn |
| Jul 31, 2024 | -1.58 Mn |
| Apr 30, 2024 | -840,121.00 |
| Apr 30, 2024 | -840,121.00 |
| Jan 31, 2024 | -767,377.00 |
| Jan 31, 2024 | -767,377.00 |
| Oct 31, 2023 | -1.06 Mn |
| Oct 31, 2023 | -1.06 Mn |